2000 North Central Expressway
Plano, TX 75074
United States
972 292 9414
https://enzolytics.com
Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo:
Nombre | Título | Paga | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Harry H. Zhabilov Jr., BSc, McS Science | CSO & Chairman | N/A | N/A | 1967 |
Steven Sharabura | Chief Executive Officer | N/A | N/A | N/A |
Mr. Charles S. Cotropia | President & Director | N/A | N/A | N/A |
Diana Zhabilov | Chief Financial Officer | N/A | N/A | N/A |
Dr. Gaurav Chandra M.D. | COO & Director | N/A | N/A | N/A |
Dr. Joseph P. Cotropia M.D. | Chief Medical Officer & Director | N/A | N/A | N/A |
Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, the company's proprietary cell line produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.
El ISS Governance QualityScore de Enzolytics, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.